GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Acorda Therapeutics, Inc. (ACOR) [hlAlert]

Rating:
Outperform
ACOR
up 27.78 %

Acorda Therapeutics, Inc. (ACOR) rated Outperform by Leerink Swann

Posted on: Monday,  Jul 23, 2012  8:29 AM ET by Leerink Swann

Leerink Swann rated Outperform Acorda Therapeutics, Inc. (NASDAQ: ACOR) on 07/23/2012. Previously Leerink Swann rated Outperform Acorda Therapeutics, Inc. (NASDAQ: ACOR)
on 07/02/2009., when the stock price was $24.80. Since then, Acorda Therapeutics, Inc. has gained 27.78% as of 01/26/2016's recent price of $31.69.
If you would have followed the previous Leerink Swann 's recommendation on ACOR, you would have gained 27.78% of your investment in 2399 days.

Acorda Therapeutics is commercial-stage biopharmaceutical company dedicated to the identification, development and commercialization of novel therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the central nervous system. Acorda currently markets Zanaflex Capsules for the management of spasticity. The Company's lead product candidate, Fampridine-SR, for the improvement of walking ability in persons with multiple sclerosis. It develops therapies that restore neurological function to people with spinal cord injury, multiple sclerosis and related conditions of the nervous system.

Leerink Swann Equity Research provides unique perspectives and agenda-setting healthcare recommendations for investors. Supported by industry-based intelligence and thorough market examination, our proprietary research enables our clients to make well-informed healthcare investment decisions. Our investment perspectives are driven by proprietary insights from MEDACorp. MEDACorp's more than 25,000 network professionals work with new and/or development-stage pharmaceuticals, medical devices and biotherapeutics on a daily basis. MEDACorp's extensive knowledge of products and research enables Leerink Swann to provide growth-focused clients an expertise earned through experience.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/23/2012 8:29 AM Buy
None
24.93
as of 12/31/2012
1 Week up  0.93 %
1 Month down  -1.38 %
3 Months down  -2.92 %
1 YTD up  4.27 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/2/2009 8:25 AM Buy
None
24.80 30.00
7/2/2009 8:25 AM Buy
None
24.80 30.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy